History of the FIGO cancer staging system

International Journal of Gynecology and Obstetrics

Volumn 101, Issue 2, 2008, Pages 205-210

  Odicino, Franco ^a,b   Pecorelli, Sergio ^a,b,c   Zigliani, Lucia ^d   Creasman, William T ^b,e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Editorial Board   (Italy)

^c FIGO Committee on Gynecologic Oncology   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

FIGO; Gynecological cancer staging system; History

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; EVIDENCE BASED MEDICINE; GYNECOLOGIC CANCER; HUMAN; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING; TROPHOBLASTIC TUMOR; UTERINE CERVIX CANCER;

EID: 41649087358     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.11.004     Document Type: Article

References (25)

1. Benedet J.L., and Pecorelli S. Why cancer staging?. Int J Gynecol Obstet 95 Suppl l (2006) S3
2. Gospodarowicz M.K., Benedet L., Hutter R.V., Fleming I., Henson D.E., and Sobin L.H. History and international developments in cancer staging. Cancer Prev Control 2 (1998) 262-268
3. In: Pecorelli S., Ngan H.Y.S., and Hacker N.F. (Eds). Staging Classifications and Clinical Practice Guidelines for Gynaecological Cancers. A collaboration between FIGO and IGCS. 3rd ed. (2006), FIGO, London
4. Bösze P. Prognostic factors and staging: the role of molecular markers. CME J Gynecol Oncol 6 (2001) 232-234
5. O'Sullivan B., Gospodarowicz M., and Mckillop W.J. Cancer staging. Cancer Prev Control 2 6 (1998) 260-261
6. Benedet J.L. Introduction. CME J Gynecol Oncol 6 (2001) 229
7. Mackillop W.J., O'Sullivan B., and Gospodarowicz M. The role of cancer staging in evidence-based medicine. Cancer Prev Control 2 6 (1998) 269-277
8. Marsden D.E., and Hacker N.F. Controversies and new trends in staging vulval and vaginal carcinoma. CME J Gynecol Oncol 6 (2001) 235-239
9. Creasman W.T. Controversies in FIGO staging of corpus cancer. CME J Gynecol Oncol 6 (2001) 257-259
10. In: Pettersson F. (Ed). Annual Report on the Results of Treatment in Gynecological Cancer (1988), FIGO Twentieth volume
11. In: Pettersson F. (Ed). Annual Report on the Results of Treatment in Gynecological Cancer (1995), FIGO Twenty-second volume
12. Benedet J.L. History of the Annual Report. Int J Gynecol Obstet 95 Suppl 1 (2006) S1-S2
13. Tropé C., Kristensen G., Onsrud M., and Bosze P. Controversies in cervical cancer staging. CME J Gynecol Oncol 6 (2001) 240-245
14. Sobin L.H., and Wittekind C.h. TNM Classification of Malignant Tumours. 6th ed. (2002), Wiley-Liss, New York
15. In: Pettersson F. (Ed). Annual Report on the Results of Treatment in Gynecological Cancer (1991), FIGO Twenty-first volume
16. Di Paola G.R. History of and rational for staging gynaecological cancers. CME J Gynecol Oncol 6 (2001) 230-231
17. de Oliveira C.F., and Mota F. Cervical cancer - pre-therapeutic investigations and clinical staging versus surgical staging. CME J Gynecol Oncol 6 (2001) 246-256
18. Maisonneuve P. Materials and methods. Int J Gynecol Obstet 95 Suppl l (2006) S5
19. In: Kottmeier H.L. (Ed). Annual Report on the Results of Treatment in Gynecological Cancer (1982), FIGO Eighteenth volume
20. Gospodarowicz M.K., Miller D., Groome P.A., Greene F.L., Logan P.A., and Sobin L.H. The process for continuous improvement of the TNM classification. Cancer 100 (2004) 1-5
21. In: Pecorelli S. (Ed). 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynecol Obstet vol. 95(Supp l) (2006) S1-S257
22. In: Pettersson F. (Ed). Annual Report on the Results of Treatment in Gynecological Cancer (1985), FIGO Nineteenth volume
23. Hermanek P. Why TNM system for staging of gynaecologic tumours?. CME J Gynecol Oncol 6 (2001) 267-269
24. Van Trappen P.O., and Jacobs I.J. Controversies and new trends in staging ovarian and Fallopian tube carcinoma. CME J Gynecol Oncol 6 (2001) 260-266
25. Benedet J.L. Conclusions. CME J Gynecol Oncol 6 (2001) 270-273